Cargando…
Human lymphoblastoid interferon in the treatment of small cell lung cancer.
Ten patients with small cell lung cancer were treated with high dose human lymphoblastoid interferon (50-100 megaunits m-2) for 5 days, followed by low dose interferon (3 megaunits m-2) for 3 weeks. At the end of treatment, and one month later, there was no evidence of either complete or partial res...
Autores principales: | Jones, D. H., Bleehen, N. M., Slater, A. J., George, P. J., Walker, J. R., Dixon, A. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011299/ https://www.ncbi.nlm.nih.gov/pubmed/6299317 |
Ejemplares similares
-
The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.
por: Twentyman, P. R., et al.
Publicado: (1985) -
RECEPTOR FOR SOLUBLE C3 AND C3b ON HUMAN LYMPHOBLASTOID (RAJI) CELLS : PROPERTIES AND BIOLOGICAL SIGNIFICANCE
por: Theofilopoulos, Argyrios N., et al.
Publicado: (1974) -
Neurotensin in human small cell lung carcinoma.
por: Goedert, M., et al.
Publicado: (1984) -
Nascent transcription upon interferon-α2 stimulation on human and rhesus macaque lymphoblastoid cell lines
por: Ramirez, Daniel, et al.
Publicado: (2023) -
Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines
por: Chhibber, A, et al.
Publicado: (2017)